Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 4 November 2019) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

(PDF, 3MB, 192 pages)

 

Export 114 results:
Author [ Title(Desc)] Type Year
Filters: Author is van Staa, T. P.  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
U
P. C. Souverein, Webb, D. J., Weil, J. G., van Staa, T. P., and Egberts, A. C., Use of antiepileptic drugs and risk of fractures: case-control study among patients with epilepsy, Neurology, vol. 66, pp. 1318-24, 2006.
F. de Vries, Souverein, P. C., Cooper, C., Leufkens, H. G., and van Staa, T. P., Use of beta-blockers and the risk of hip/femur fracture in the United Kingdom and The Netherlands, Calcif Tissue Int, vol. 80, pp. 69-75, 2007.
T. P. van Staa, Abenhaim, L., and Cooper, C., Use of cyclical etidronate and prevention of non-vertebral fractures, Br J Rheumatol, vol. 37, pp. 87-94, 1998.
T. P. van Staa, Leufkens, H. G., and Cooper, C., Use of inhaled corticosteroids and risk of fractures, J Bone Miner Res, vol. 16, pp. 581-8, 2001.
T. P. van Staa, Cooper, C., Leufkens, H. G., Lammers, J. W., and Suissa, S., The use of inhaled corticosteroids in the United Kingdom and the Netherlands, Respir Med, vol. 97, pp. 578-85, 2003.
T. P. van Staa, Leufkens, H. G., and Cooper, C., Use of nonsteroidal anti-inflammatory drugs and risk of fractures, Bone, vol. 27, pp. 563-8, 2000.
T. P. van Staa, Leufkens, H. G., Abenhaim, L., Zhang, B., and Cooper, C., Use of oral corticosteroids and risk of fractures, J Bone Miner Res, vol. 15, pp. 993-1000, 2000.
T. P. van Staa, Leufkens, H. G., Abenhaim, L., Begaud, B., Zhang, B., and Cooper, C., Use of oral corticosteroids in the United Kingdom, Qjm, vol. 93, pp. 105-11, 2000.
P. C. Souverein, Berard, A., van Staa, T. P., Cooper, C., Egberts, A. C., Leufkens, H. G., and Walker, B. R., Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study, Heart, vol. 90, pp. 859-65, 2004.
T. P. van Staa, Wegman, S., de Vries, F., Leufkens, B., and Cooper, C., Use of statins and risk of fractures, Jama, vol. 285, pp. 1850-5, 2001.
T. P. van Staa, Leufkens, H. G., and Cooper, C., Utility of medical and drug history in fracture risk prediction among men and women, Bone, vol. 31, pp. 508-14, 2002.
A. M. Gallagher, Leighton-Scott, J., and van Staa, T. P., Utilization characteristics and treatment persistence in patients prescribed low-dose buprenorphine patches in primary care in the United Kingdom: a retrospective cohort study, Clin Ther, vol. 31, pp. 1707-15, 2009.
[Page last reviewed 4 November 2019]